Spain Celiac Disease Treatment Market Size & Outlook

The celiac disease treatment market in Spain is expected to reach a projected revenue of US$ 39.6 million by 2030. A compound annual growth rate of 12.2% is expected of Spain celiac disease treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$19.8
Forecast, 2030 (US$M)
$39.6
CAGR, 2025 - 2030
12.2%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain celiac disease treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain celiac disease treatment market highlights

  • The Spain celiac disease treatment market generated a revenue of USD 19.8 million in 2024 and is expected to reach USD 39.6 million by 2030.
  • The Spain market is expected to grow at a CAGR of 12.2% from 2025 to 2030.
  • In terms of segment, vitamins & minerals was the largest revenue generating treatment in 2024.
  • Gluten Degrading Enzymes is the most lucrative treatment segment registering the fastest growth during the forecast period.


Celiac disease treatment market data book summary

Market revenue in 2024USD 19.8 million
Market revenue in 2030USD 39.6 million
Growth rate12.2% (CAGR from 2025 to 2030)
Largest segmentVitamins & minerals
Fastest growing segmentGluten Degrading Enzymes
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationVitamins & Minerals, Gluten Degrading Enzymes, Symptomatic Treatment (Anti-inflammatory drugs, Antihistamines, others), Other Treatments
Key market players worldwideTeva Pharmaceutical Industries Ltd, Amgen Inc, Amneal Pharmaceuticals, Takeda Pharmaceutical Co Ltd, Hikma Pharmaceuticals PLC, Viatris Inc, Novartis AG ADR, BioLine Rx Ltd ADR


Other key industry trends

  • In terms of revenue, Spain accounted for 2.9% of the global celiac disease treatment market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany celiac disease treatment market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 51.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Celiac Disease Treatment Market Companies

Name Profile # Employees HQ Website
Amneal Pharmaceuticals View profile 5001-10000 Bridgewater, New Jersey, United States, North America http://amneal.com/
BioLine Rx Ltd ADR View profile 79 2 HaMa’ayan Street, Modi’in, Israel, 7177871 https://www.biolinerx.com
Hikma Pharmaceuticals PLC View profile 2150 1 New Burlington Place, London, United Kingdom, W1S 2HR https://www.hikma.com
Takeda Pharmaceutical Co Ltd View profile 49095 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 https://www.takeda.com
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Spain celiac disease treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to celiac disease treatment market will help companies and investors design strategic landscapes.


Vitamins & minerals was the largest segment with a revenue share of 39.9% in 2024. Horizon Databook has segmented the Spain celiac disease treatment market based on vitamins & minerals, gluten degrading enzymes, symptomatic treatment (anti-inflammatory drugs, antihistamines, others), other treatments covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Spain celiac disease treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain celiac disease treatment market databook

  • Our clientele includes a mix of celiac disease treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain celiac disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Spain celiac disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain celiac disease treatment market size, by treatment, 2018-2030 (US$M)

Spain Celiac Disease Treatment Market Outlook Share, 2024 & 2030 (US$M)

Spain celiac disease treatment market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online